Cargando…
Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats
Tobacco smoking is the cause of 20% of Canadian deaths per year. Nicotine vaccines present a promising alternative to traditional smoking cessation products, but to date, no vaccine has been able to move through all phases of clinical trials. We have previously demonstrated that the AFPL1-conjugate...
Autores principales: | Oliva, Reynaldo, Fraleigh, Nya L., Lewicky, Jordan D., Fariñas, Mildrey, Hernández, Tamara, Martel, Alexandrine L., Navarro, Ingrid, Dagmar, García-Rivera, Acevedo, Reinaldo, Le, Hoang-Thanh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955701/ https://www.ncbi.nlm.nih.gov/pubmed/31771151 http://dx.doi.org/10.3390/pharmaceutics11120626 |
Ejemplares similares
-
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
por: Fraleigh, Nya L., et al.
Publicado: (2019) -
Case Reports of Situs Inversus Totalis and Dextrocardia in Sprague Dawley Rats
por: Hernández, Reynaldo Oliva, et al.
Publicado: (2019) -
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)
por: Fraleigh, Nya L., et al.
Publicado: (2016) -
Assessing Neutralized Nicotine Distribution Using Mice Vaccinated with the Mucosal Conjugate Nicotine Vaccine
por: Fraleigh, Nya L., et al.
Publicado: (2021) -
Enhancing the Immune Response of a Nicotine Vaccine with Synthetic Small “Non-Natural” Peptides
por: Le, Hoang-Thanh, et al.
Publicado: (2020)